SS

Suhel Sami Khatib

Active Director Director DIN 00904454 Hurun Rich List · #1,608
DIN 00904454 First appointment Feb 1986 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Feb 1986
Shareholding value •••• Premium profile

About Suhel Sami Khatib

Data last updated:

Suhel Sami Khatib has 40 years in corporate governance. Holds Director role. Currently with 3 companies, including Sorbo Monni Chemicals Private Limited and Minar Chemicals Pvt Ltd. Formerly with 2 companies, such as Biogen Laboratories (India) Private Limited and Blue-Fin Frozen Foods Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹1,116 Cr; the largest is Medley Pharmaceuticals Limited at ₹1,115 Cr (FY 2025).

Suhel Khatib is #1,608 on the Hurun India Rich List 2026, with wealth of ₹1,200 Cr.

DIN 00904454
Primary Designation Director
First Appointment 27 Feb 1986
Oldest Company Age 51 yrs
Largest company Medley Pharmaceuticals Limited · ₹1,115 Cr (FY 2025)
Combined revenue ₹1,116 Cr across 3 companies

Recognitions & Rankings

Hurun India Rich List 2026 edition
Rank#1,608
Wealth
₹1,200 Cr
Company
Medley Pharmaceuticals

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medley Pharmaceuticals Limited U24230MH1975PLC018296
Director01 Apr 20101975₹1,115 Cr (FY 2025)Active
Minar Chemicals Pvt Ltd U24116MH1982PTC169259
Director25 May 19881982₹62.5 Lakh (FY 2017)Active
Director06 Jan 19881983₹31.2 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 19861986₹9.2 Lakh (FY 2025)Active
Nominee Director12 Oct 20102008₹118 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sorbo Monni Chemicals Private Limited
Minar Chemicals Pvt Ltd
Medley Pharmaceuticals Limited
Biogen Laboratories (India) Private Limited
Premium access

Shareholding and investment profile for Suhel Sami Khatib

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suhel Sami Khatib

Suhel Sami Khatib has 40 years in corporate governance. Holds Director role. Currently with 3 companies, including Sorbo Monni Chemicals Private Limited and Minar Chemicals Pvt Ltd. Formerly with 2 companies, such as Biogen Laboratories (India) Private Limited and Blue-Fin Frozen Foods Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹1,116 Cr; the largest is Medley Pharmaceuticals Limited at ₹1,115 Cr (FY 2025).

Suhel Sami Khatib is associated with 3 companies as Director, including Medley Pharmaceuticals Limited (₹1,115 Cr), Minar Chemicals Pvt Ltd (₹62.5 Lakh), Sorbo Monni Chemicals Private Limited (₹31.2 Lakh).

Suhel Sami Khatib has expertise in General Business.

Suhel Sami Khatib has 40 years in corporate governance.

By reported revenue, the largest current company of Suhel Sami Khatib is Medley Pharmaceuticals Limited, with revenue of ₹1,115 Cr (FY 2025).

The 3 current companies of Suhel Sami Khatib that report revenue have a combined latest revenue of ₹1,116 Cr.

Suhel Sami Khatib currently holds positions at 3 companies: Medley Pharmaceuticals Limited (₹1,115 Cr), Minar Chemicals Pvt Ltd (₹62.5 Lakh), Sorbo Monni Chemicals Private Limited (₹31.2 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available